D.E. Shaw & Co
THAC

D.E. Shaw & Co’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

D.E. Shaw & Co’s Portfolio THAC Stock Details THAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,435,159
Closed -$14.8M – 5199
2022
Q4 		$14.8M Buy
1,435,159
+200,001
+16% +$2.05M 0.02% 1126
2022
Q3 		$12.5M Buy
1,235,158
+189,467
+18% +$1.91M 0.02% 1170
2022
Q2 		$10.5M Buy
1,045,691
+245,285
+31% +$2.46M 0.01% 1344
2022
Q1 		$8M Buy
800,406
+178,724
+29% +$1.78M 0.01% 1817
2021
Q4 		$6.2M Buy
+621,682
New +$6.15M 0.01% 2148

D.E. Shaw & Co's THAC Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 1,435,159 shares — an estimated $14.8M sold.

D.E. Shaw & Co first reported a position in THAC in Q4 2021 and held it in 5 quarters. The position peaked at $14.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,435,159 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $14.8M.
  • D.E. Shaw & Co first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's Thrive Acquisition Corporation Class A ordinary shares position peaked at $14.8M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.